Literature DB >> 22127794

Balanced steady-state free precession fMRI with intravascular susceptibility contrast agent.

Iris Y Zhou1, Matthew M Cheung, Condon Lau, Kevin C Chan, Ed X Wu.   

Abstract

One major challenge in echo planar imaging-based functional MRI (fMRI) is the susceptibility-induced image distortion. In this study, a new cerebral blood volume-weighted fMRI technique using distortion-free balanced steady-state free precession (bSSFP) sequence was proposed and its feasibility was investigated in rat brain at 7 Tesla. After administration of intravascular susceptibility contrast agent (monocrystalline iron oxide nanoparticle [MION] at 15 mg/kg), unilateral visual stimulation was presented using a block-design paradigm. With repetition time/echo time = 3.8/1.9 ms and α = 18°, bSSFP fMRI was performed and compared with the conventional cerebral blood volume-weighted fMRI using post-MION gradient echo and spin echo echo planar imaging. The results showed that post-MION bSSFP fMRI provides comparable sensitivity but with no severe image distortion and signal dropout. Robust negative responses were observed during stimulation and activation patterns were in excellent agreement with known neuroanatomy. Furthermore, the post-MION bSSFP signal was observed to decrease significantly during hypercapnia challenge, indicating its sensitivity to cerebral blood volume changes. These findings demonstrated that post-MION bSSFP fMRI is a promising alternative to conventional cerebral blood volume-weighted fMRI. This technique is particularly suited for fMRI investigation of animal models at high field.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127794     DOI: 10.1002/mrm.23202

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

1.  Long-range projections coordinate distributed brain-wide neural activity with a specific spatiotemporal profile.

Authors:  Alex T L Leong; Russell W Chan; Patrick P Gao; Ying-Shing Chan; Kevin K Tsia; Wing-Ho Yung; Ed X Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-05       Impact factor: 11.205

2.  In vivo visuotopic brain mapping with manganese-enhanced MRI and resting-state functional connectivity MRI.

Authors:  Kevin C Chan; Shu-Juan Fan; Russell W Chan; Joe S Cheng; Iris Y Zhou; Ed X Wu
Journal:  Neuroimage       Date:  2014-01-04       Impact factor: 6.556

3.  Long-term effects of neonatal hypoxia-ischemia on structural and physiological integrity of the eye and visual pathway by multimodal MRI.

Authors:  Kevin C Chan; Swarupa Kancherla; Shu-Juan Fan; Ed X Wu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

Review 4.  Physiological and Functional Magnetic Resonance Imaging Using Balanced Steady-state Free Precession.

Authors:  Sung-Hong Park; Paul Kyu Han; Seung Hong Choi
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

5.  3D functional ultrasound imaging of the cerebral visual system in rodents.

Authors:  Marc Gesnik; Kevin Blaize; Thomas Deffieux; Jean-Luc Gennisson; José-Alain Sahel; Mathias Fink; Serge Picaud; Mickaël Tanter
Journal:  Neuroimage       Date:  2017-02-03       Impact factor: 6.556

6.  Optogenetic fMRI interrogation of brain-wide central vestibular pathways.

Authors:  Alex T L Leong; Yong Gu; Ying-Shing Chan; Hairong Zheng; Celia M Dong; Russell W Chan; Xunda Wang; Yilong Liu; Li Hai Tan; Ed X Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-26       Impact factor: 11.205

7.  Noninvasive fMRI investigation of interaural level difference processing in the rat auditory subcortex.

Authors:  Condon Lau; Jevin W Zhang; Joe S Cheng; Iris Y Zhou; Matthew M Cheung; Ed X Wu
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  Resting-state fMRI using passband balanced steady-state free precession.

Authors:  Joe S Cheng; Patrick P Gao; Iris Y Zhou; Russell W Chan; Queenie Chan; Henry K Mak; Pek L Khong; Ed X Wu
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.